0001127602-12-033818.txt : 20121213
0001127602-12-033818.hdr.sgml : 20121213
20121213153024
ACCESSION NUMBER: 0001127602-12-033818
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121211
FILED AS OF DATE: 20121213
DATE AS OF CHANGE: 20121213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EBERLY RICHARD
CENTRAL INDEX KEY: 0001224658
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14902
FILM NUMBER: 121262043
MAIL ADDRESS:
STREET 1: 3471 RIVER HILLS DRIVE
CITY: CINCINNATI
STATE: OH
ZIP: 45244
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC
CENTRAL INDEX KEY: 0000794172
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 310888197
STATE OF INCORPORATION: OH
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 3471 RIVER HILLS DR
CITY: CINCINNATI
STATE: OH
ZIP: 45244
BUSINESS PHONE: 5132713700
MAIL ADDRESS:
STREET 1: 3471 RIVER HILLS DRIVE
CITY: CINCINNATI
STATE: OH
ZIP: 45244
FORMER COMPANY:
FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2012-12-11
0000794172
MERIDIAN BIOSCIENCE INC
VIVO
0001224658
EBERLY RICHARD
3471 RIVER HILLS DRIVE
CINCINNATI
OH
45244
1
EVP,Pres Meridian Life Science
Common Stock
2012-12-11
4
M
0
5250
0
A
42996
D
Common Stock
2012-12-11
4
M
0
10500
0
A
53496
D
Common Stock
2012-12-11
4
M
0
15750
0
A
69246
D
Common Stock
2012-12-11
4
S
0
31500
20.4654
D
37746
D
Stock Options (Right to Buy)
7.28
2012-12-11
4
M
0
5250
0
D
2014-12-07
Common Stock
5250
0
D
Stock Options (Right to Buy)
14.007
2012-12-11
4
M
0
10500
0
D
2015-11-10
Common Stock
10500
0
D
Stock Options (Right to Buy)
16.554
2012-12-11
4
M
0
15750
0
D
2016-11-15
Common Stock
15750
0
D
Prices range from $20.3766 per share to $20.5609 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
These options became fully vested in November 2008.
These options became fully vested in November 2009.
These options became fully vested in November 2010.
/s/ Melissa A. Lueke as Attorney-in-Fact for Richard Eberly
2012-12-13